Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Roles of the circular RNA circ-Foxo3 in breast cancer progression.

Literature DB >> 28278047

Roles of the circular RNA circ-Foxo3 in breast cancer progression.

Wei-Yang Lu^1,2.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2017 PMID： 28278047 PMCID： PMC5397257 DOI： 10.1080/15384101.2017.1278935

Source DB: PubMed Journal: Cell Cycle ISSN： 1551-4005 Impact factor: 4.534

× No keyword cloud information.

7 in total

1. Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis.

Authors: W Yang; W W Du; X Li; A J Yee; B B Yang
Journal: Oncogene Date: 2015-12-14 Impact factor: 9.867

2. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.

Authors: William W Du; Ling Fang; Weining Yang; Nan Wu; Faryal Mehwish Awan; Zhenguo Yang; Burton B Yang
Journal: Cell Death Differ Date: 2016-11-25 Impact factor: 15.828

3. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.

Authors: Diego Sisci; Pamela Maris; Maria Grazia Cesario; Wanda Anselmo; Roberta Coroniti; Giovanna Elvi Trombino; Francesco Romeo; Aurora Ferraro; Marilena Lanzino; Saveria Aquila; Marcello Maggiolini; Loredana Mauro; Catia Morelli; Sebastiano Andò
Journal: Cell Cycle Date: 2013-09-17 Impact factor: 4.534

4. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway.

Authors: Fang Li; Liyuan Zhang; Wei Li; Jieqiong Deng; Jian Zheng; Mingxing An; Jiachun Lu; Yifeng Zhou
Journal: Oncotarget Date: 2015-03-20

5. The anti-cancer components of Ganoderma lucidum possesses cardiovascular protective effect by regulating circular RNA expression.

Authors: Yi-Zhen Xie; Fenghua Yang; Weijiang Tan; Xiangmin Li; Chunwei Jiao; Ren Huang; Burton B Yang
Journal: Oncoscience Date: 2016-08-28

6. An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.

Authors: Linda Smit; Katrien Berns; Katherine Spence; W David Ryder; Nik Zeps; Mandy Madiredjo; Roderick Beijersbergen; René Bernards; Robert B Clarke
Journal: Oncotarget Date: 2016-01-19

7. Circular RNAs and their associations with breast cancer subtypes.

Authors: Asha A Nair; Nifang Niu; Xiaojia Tang; Kevin J Thompson; Liewei Wang; Jean-Pierre Kocher; Subbaya Subramanian; Krishna R Kalari
Journal: Oncotarget Date: 2016-12-06

7 in total

26 in total

10. Identification and comparison of novel circular RNAs with associated co-expression and competing endogenous RNA networks in pulmonary tuberculosis.

Authors: Xing Zhang; Min Zhu; Rong Yang; Weifeng Zhao; Xiaolong Hu; Jianhe Gan
Journal: Oncotarget Date: 2017-11-27

Roles of the circular RNA circ-Foxo3 in breast cancer progression.

1. Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis.

2. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.

3. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.

4. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway.

5. The anti-cancer components of Ganoderma lucidum possesses cardiovascular protective effect by regulating circular RNA expression.

6. An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.

7. Circular RNAs and their associations with breast cancer subtypes.

Review 1. The role of noncoding RNAs in epithelial cancer.

2. Circular RNA Vav3 sponges gga-miR-375 to promote epithelial-mesenchymal transition.

3. Circular RNA circRPPH1 promotes triple-negative breast cancer progression via the miR-556-5p/YAP1 axis.

Review 4. The progress of circular RNAs in various tumors.

5. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.

6. Cancer-Associated circRNA-miRNA-mRNA Regulatory Networks: A Meta-Analysis.

7. Unique expression signatures of circular RNAs in response to DNA tumor virus SV40 infection.

8. CircRNAs as biomarkers of cancer: a meta-analysis.

Review 9. Circular RNAs in cancer: opportunities and challenges in the field.

10. Identification and comparison of novel circular RNAs with associated co-expression and competing endogenous RNA networks in pulmonary tuberculosis.